| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 289 | 330 | 214 | 246 | 325 | 311 | 443 | 492 | 534 | 659 | 671 | 719 |
| Expenses | 254 | 290 | 184 | 220 | 291 | 284 | 387 | 440 | 476 | 572 | 601 | 650 |
| EBITDA | 35 | 40 | 30 | 25 | 34 | 27 | 55 | 52 | 57 | 87 | 70 | 70 |
| Operating Profit % | 11 % | 11 % | 11 % | 8 % | 9 % | 7 % | 10 % | 10 % | 10 % | 12 % | 9 % | 9 % |
| Depreciation | 3 | 2 | 2 | 2 | 2 | 7 | 15 | 12 | 10 | 9 | 9 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 1 |
| Profit Before Tax | 32 | 38 | 28 | 23 | 32 | 19 | 39 | 39 | 48 | 78 | 61 | 60 |
| Tax | 10 | 12 | 8 | 7 | 9 | 5 | 10 | 9 | 11 | 18 | 14 | 15 |
| Net Profit | 22 | 26 | 20 | 17 | 23 | 14 | 28 | 31 | 36 | 60 | 47 | 46 |
| EPS in ₹ | 8.78 | 10.30 | 8.00 | 6.59 | 9.33 | 2.85 | 5.67 | 6.10 | 7.22 | 11.98 | 9.45 | 9.20 |
Anuh Pharma
Anuh Pharma
88.56
+0.41
(0.47%)
Market Cap
887.58 Cr
EPS
9.45
PE Ratio
19.16
Dividend Yield
0.85 %
Industry
Healthcare52 Week High
122.85
52 Week Low
74.25
PB Ratio
2.71
Debt to Equity
0.02
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Anuh Pharma Limited's 65th Annual General Meeting approved several key appointments and reappointments. The company reappointed Bharat Nemchand Shah and Gaurav Satish Shah as Non-Executive Non-Independent Directors, with Shah having 5 decades of pharma experience and Gaurav holding 20 years of industry experience with a Bachelor's in Engineering from the USA. Ankit Kishor Chande was reappointed as Cost Auditor for financial year ending March 2026, bringing over 12 years of experience across 17 industries. GHV & Co. was appointed as Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30. The meeting also approved the reappointment of Joint Managing Directors Ritesh Shah and Vivek Shah for five years from January 8, 2026 to January 7, 2031. Ritesh Shah brings 21 years of pharmaceutical experience in marketing and strategy, while Vivek Shah has over 15 years in operations, R&D, and regulatory affairs. Both Joint Managing Directors are sons of Vice Chairman Bipin Nemchand Shah.
Anuh Pharma Limited's Board approved unaudited financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs 18,647.94 lakhs compared to Rs 13,790.83 lakhs in the same quarter last year. Profit after tax stood at Rs 830.12 lakhs versus Rs 950.91 lakhs in the corresponding quarter of the previous year. Basic earnings per share was Rs 1.66 compared to Rs 1.90 in the year-ago quarter. EBITDA margin was 7.34% for the quarter. The Board also appointed Mr. Vinayak Shenoy as Chief Marketing Officer effective August 11, 2025. Shenoy brings over 15 years of experience in APIs and Intermediates with expertise in global markets including USA, Europe, CIS, SEA, LATAM, and India.
Anuh Pharma Sets Revised Record Date for FY 2024-25 Final Dividend and AGM Voting RightsJul 29, 2025
Anuh Pharma Limited has announced a revised record date of August 15, 2025, for determining shareholder eligibility for the final dividend for FY 2024-25 and voting rights for the Annual General Meeting. The company's 65th AGM is scheduled for August 22, 2025, at 4:00 PM IST at Hall of Harmony, Nehru Centre, Mumbai. The final dividend is subject to declaration and approval by members at the AGM. Shareholders will be entitled to vote through remote e-voting facility or at the AGM. The Notice of AGM and Annual Report will be sent to shareholders separately.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,601.70 | #1 3,84,301.48 | 33.81 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 49.00 | |
6,060.00 | 1,60,873.96 | 69.37 | 9,712.00 | 18.67 | 2,191 | 26.74 | 39.47 | |
1,547.90 | 1,25,025.09 | 23.57 | 28,409.50 | 7.12 | 5,291 | 9.88 | 52.08 | |
3,530.10 | 1,19,474.62 | 59.77 | 11,539.40 | 6.99 | 1,911 | 19.91 | 48.74 | |
1,300.00 | 1,08,494.24 | #1 19.34 | 33,741.20 | 16.73 | 5,725 | 1.26 | 60.35 | |
2,589.00 | 1,06,855.47 | 56.33 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 58.41 | |
1,036.75 | 1,04,321.31 | 22.55 | 23,511.00 | 18.55 | 4,615 | 2.60 | 68.18 | |
2,046.10 | 93,444.46 | 25.22 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 59.44 | |
5,499.00 | 65,748.79 | 28.64 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.73 | |
30,850.00 | 65,554.10 | 45.31 | 6,684.70 | 9.64 | 1,414 | 11.55 | 39.39 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
1.81 %
Net Income Growth
-21.13 %
Cash Flow Change
187.08 %
ROE
-29.58 %
ROCE
-30.06 %
EBITDA Margin (Avg.)
-20.77 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 168 | 193 | 189 | 209 | 240 | 326 | 333 | 347 | 405 | 446 | 507 |
| Fixed Assets | 10 | 18 | 17 | 17 | 21 | 84 | 71 | 61 | 53 | 49 | 58 |
| Current Assets | 144 | 151 | 138 | 154 | 152 | 223 | 238 | 259 | 308 | 339 | 376 |
| Capital Work in Progress | 0 | 0 | 0 | 6 | 34 | 0 | 0 | 0 | 0 | 1 | 0 |
| Investments | 29 | 22 | 70 | 66 | 39 | 80 | 31 | 43 | 91 | 97 | 106 |
| Other Assets | 129 | 152 | 101 | 120 | 147 | 163 | 230 | 243 | 261 | 300 | 342 |
| Total Liabilities | 168 | 193 | 189 | 209 | 240 | 326 | 333 | 347 | 405 | 446 | 507 |
| Current Liabilities | 67 | 73 | 47 | 59 | 75 | 163 | 140 | 131 | 161 | 153 | 179 |
| Non Current Liabilities | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 2 | 2 |
| Total Equity | 101 | 119 | 141 | 150 | 165 | 162 | 191 | 214 | 241 | 291 | 326 |
| Reserve & Surplus | 97 | 107 | 128 | 137 | 152 | 150 | 166 | 189 | 216 | 266 | 301 |
| Share Capital | 4 | 13 | 13 | 13 | 13 | 13 | 25 | 25 | 25 | 25 | 25 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 2 | 2 | -1 | 4 | -5 | 0 | 2 | -2 | 5 | 12 |
| Investing Activities | -12 | -5 | -20 | 2 | 3 | -77 | 52 | -8 | -44 | 1 | -20 |
| Operating Activities | 19 | 17 | 26 | 2 | 7 | 49 | -19 | 29 | 54 | 13 | 37 |
| Financing Activities | -8 | -9 | -4 | -5 | -7 | 22 | -33 | -20 | -12 | -9 | -5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 |
| Promoter | 70.47 % | 70.43 % | 70.43 % | 70.45 % | 70.44 % | 70.59 % | 70.59 % | 70.59 % | 70.59 % | 70.59 % | 70.59 % | 69.94 % | 69.92 % | 69.92 % | 69.92 % | 69.92 % | 69.92 % | 69.92 % | 69.92 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.03 % | 0.03 % | 0.02 % | 0.02 % | 0.04 % | 0.04 % | 0.03 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.11 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 26.04 % | 26.27 % | 26.33 % | 26.26 % | 26.16 % | 26.18 % | 26.12 % | 26.00 % | 25.94 % | 25.68 % | 25.79 % | 26.14 % | 26.20 % | 26.30 % | 26.27 % | 26.02 % | 25.92 % | 25.89 % | 25.83 % |
| Others | 3.49 % | 3.30 % | 3.25 % | 3.29 % | 3.41 % | 3.23 % | 3.28 % | 3.41 % | 3.47 % | 3.73 % | 3.61 % | 3.92 % | 3.75 % | 3.75 % | 3.79 % | 4.04 % | 4.13 % | 4.16 % | 4.23 % |
| No of Share Holders | 19,442 | 22,457 | 22,779 | 21,500 | 21,123 | 20,740 | 20,452 | 20,470 | 19,969 | 19,423 | 19,066 | 20,519 | 22,237 | 23,494 | 23,910 | 24,048 | 24,235 | 24,257 | 26,157 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.5 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.35 | 1.7 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Sept 2020 |  Bonus | 1:1 | 18 Sept 2020 | 90.73 | 103.15 |
| 19 Aug 2021 |  Dividend | ₹ 1.50 /share | 17 Aug 2021 | 75.38 | 60.50 |
| 05 Aug 2022 | Dividend | ₹ 1.75 /share | 03 Aug 2022 | 46.15 | 50.50 |
| 11 Aug 2023 | Dividend | ₹ 2.00 /share | 11 Aug 2023 | 46.97 | 66.08 |
| 16 Aug 2024 | Dividend | ₹ 2.50 /share | 16 Aug 2024 | 120.33 | 103.55 |
| 23 Aug 2024 |  Annual General Meeting | NA | 23 Aug 2024 | 120.33 | 105.05 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 95.45 | 100.33 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 97.33 | 102.43 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 90.35 | 106.08 |
| 15 Jul 2025 | Bonus | 1:1 | 15 Jul 2025 | 110.41 | 103.88 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 97.90 | 90.45 |
| 15 Aug 2025 | Dividend | ₹ 1.50 /share | 14 Aug 2025 | 106.08 | 88.30 |
| 22 Aug 2025 | Annual General Meeting | NA | 22 Aug 2025 | 106.08 | 92.05 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in ManagementAug 26, 2025
Aug 26, 2025Announcement Under Regulation 30 - General UpdatesAug 26, 2025
Aug 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 26, 2025
Aug 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 22, 2025
Aug 22, 2025Intimation Regarding 100 Days Campaign - Saksham NiveshakAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Aug 08, 2025Results-Financial Results For June 30 2025Aug 08, 2025
Aug 08, 2025Board Meeting Outcome for Outcome For The Board Meeting Held On 08/08/2025Aug 08, 2025
Aug 08, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2025.Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Jul 30, 2025Shareholder Meeting - Rectified Covering Letter For Notice Of Annual General Meeting On Friday 22Nd August 2025Jul 29, 2025
Jul 29, 2025Corporate Action - Fixes Revised Record Date For Dividend And Annual General MeetingJul 29, 2025
Jul 29, 2025General UpdatesJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Jul 29, 2025Reg. 34 (1) Annual Report.Jul 29, 2025
Jul 29, 2025Shareholder Meeting - Annual General Meeting On Friday 22Nd August 2025Jul 29, 2025
Jul 29, 2025Clarification Sought From Anuh Pharma LtdJul 22, 2025
Jul 22, 2025Clarification sought from Anuh Pharma LtdJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-AllotmentJul 16, 2025
Jul 16, 2025Announcement Under Regulation 30 (LODR) - Inauguration Of Manufacturing Block INT 1A Of The Company.Jul 15, 2025
Jul 15, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 08, 2025
Jul 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Corporate Action - Record Date For Issue Of Bonus Equity Shares Of The Company.Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 07, 2025
Jun 07, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 06, 2025
Jun 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2025
May 29, 2025Corporate Action - Fixes Record Date For Dividend And Annual General MeetingMay 28, 2025
May 28, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 25, 2025
May 25, 2025Announcement Under Regulation 30 (LODR)May 23, 2025
May 23, 2025Announcement Under Regulation 30 (LODR)May 23, 2025
May 23, 2025Announcement Under Regulation 30 (LODR)May 23, 2025
May 23, 2025Announcement Under Regulation 30 (LODR)May 23, 2025
May 23, 2025Announcement Under Regulation 30 (LODR)May 23, 2025
May 23, 2025Announcement Under Regulation 30 (LODR) Appointment Of Secretarial AuditorsMay 23, 2025
May 23, 2025Corporate Action-Board recommends Bonus IssueMay 23, 2025
May 23, 2025Corporate Action-Board approves DividendMay 23, 2025
May 23, 2025Revised Results - Financial Results For March 31 2025 (Quarter And Year Ended 31/03/2025)May 23, 2025
May 23, 2025Board Meeting Outcome for Revised Outcome For The Board Meeting Dated 23/05/2025May 23, 2025
May 23, 2025Results - Financials Results For The Year Ended 31/03/2025May 23, 2025
May 23, 2025Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 23/05/2025May 23, 2025
May 23, 2025Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Financial Year Ended 31St March 2025 Proposal Of Bonus Issue If Any And Subject To Approval And Recommendation Of Final Dividend If Any For The Financial Year 202May 19, 2025
May 19, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Apr 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Technical Indicators
RSI(14)
Neutral 46.97
ATR(14)
Less Volatile 3.46
STOCH(9,6)
Neutral 29.27
STOCH RSI(14)
Overbought 87.71
MACD(12,26)
Bullish 0.56
ADX(14)
Weak Trend 19.40
UO(9)
Bearish 33.29
ROC(12)
Uptrend And Accelerating 0.87
WillR(14)
Neutral -53.89
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
